
Industry needs to realize the potential that new treatments and technologies hold and put skills at the top of its collective agenda, write Ian Marison and Peter Levison.
Prof. Ian Marison is founder and CEO of the Biofactory Competence Center SA, Fribourg, Switzerland and part-time professor of bioprocess engineering at the HEAI-FR. Prior to this he was a professor for many years in Dublin and formerly CEO of NIBRT, Ireland. Dr. Peter Levison is Executive Director Business Development for Pall Biotech and is responsible for developing strategic partnerships within the Biotech community through the management of a network of global thought leaders, working with key industrialists and academics around the world.
Published: April 17th 2019 | Updated: